Bibliographical noteFunding Information:
This publication presents independent research supported by the Health Innovation Challenge Fund (HICF-T5-342 and WT098600), a parallel funding partnership between the Department of Health and Wellcome Trust. The views expressed in this publication are those of the authors and not necessarily those of the Department of Health or Wellcome Trust.
This work was supported by a grant from the Department of Health , Wellcome Trust and the Health Innovation Challenge Fund ( HICF-T5-342 and WT098600 ) and Public Health England (to S.J.P.). C.U.K. is a Junior Research Fellow at Wolfson College, Cambridge. I.C. is supported by the Spanish Government (Ramón y Cajal programme RYC-2012-10627).
- Mycobacterium tuberculosis complex
- Phylogenetic diversity
- Pyrazinamide resistance